Trial
NCT00665665
Safety, Efficacy, Tolerability and Pharmacokinetics of NNC 0070-0002-0182 in Overweight or Obese Male and Female Volunteers
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Novo Nordisk A/S
Collaborators
—
Condition
Metabolism and Nutrition Disorder
Intervention
NNC 0070-0002-0182
Why stopped
The trial is terminated due to re-evaluation of the compound
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-12-23